Naohiro Sugitani

6PUBLICATIONS
11CO-AUTHORS
Respiratory diseasesRheumatology and arthritisHaematological tumoursAutoimmunitySocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2026
Retention Rates of Biological Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Reduced Kidney Function: Analysis From the IORRA Cohort.

|Dec 16, 2024
Higher risk of poor functional outcome and unfavourable clinical events for late-onset rheumatoid arthritis: results from the IORRA cohort.

Naohiro Sugitani, Eiichi Tanaka, Eisuke Inoue

|Jul 17, 2024
Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry.

Masayoshi Harigai, Eiichi Tanaka, Eisuke Inoue

|Jun 28, 2023
Impact of interstitial lung disease on clinical remission and unfavourable events of rheumatoid arthritis: results from the IORRA cohort.

Eri Sugano, Eiichi Tanaka, Eisuke Inoue

|Feb 14, 2023
Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort.

Naohiro Sugitani, Eiichi Tanaka, Eisuke Inoue

|Nov 16, 2022
Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data.

Eiichi Tanaka, Eisuke Inoue, Ayako Shoji

Pageof 1

Frequent Collaborators

6 joint publications

Eiichi Tanaka

4 joint publications

Masayoshi Harigai

1 joint publications

Ayako Shoji

1 joint publications

Katsunori Ikari